# Ideal Dosage for Sedation of Obese Patients Undergoing Knee or Hip Arthroplasty Under Spinal Anesthesia

> **NCT05760534** · PHASE4 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 110 (actual)

## Conditions studied

- Arthritis Knee
- Arthritis Hip

## Interventions

- **DRUG:** Remimazolam

## Key facts

- **NCT ID:** NCT05760534
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-06
- **Primary completion:** 2025-11-25
- **Final completion:** 2025-11-25
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2025-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05760534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05760534, "Ideal Dosage for Sedation of Obese Patients Undergoing Knee or Hip Arthroplasty Under Spinal Anesthesia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05760534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*